In a modified intention-to-treat analysis, transplant-free survival after 12 months among French patients who took 550 mg of rifaximin twice daily was 58% compared with 65% for those who took a ...
Acute-on-chronic liver failure (ACLF) is a critical and often fatal syndrome characterized by a sudden exacerbation of chronic liver disease, leading to multi-organ failure and high short-term ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback